Press Releases

SEATTLE, July 9, 2019 /PRNewswire/ -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker stability assay services for antibody drug conjugates (ADCs).  ReachBio has developed two distinct assay platforms to assess cytotoxicity caused by AD

LAFAYETTE, Colo., July 9, 2019 /PRNewswire/ -- KPA, a leading provider of Environmental Health & Safety (EHS), HR Management, and Finance & Insurance compliance software and services, ann

ROSEVILLE, Calif., July 9, 2019 /PRNewswire/ -- US Kidney Research Corporation (formerly Curion Research Corp) has created a new technology for cleansing the blood of patients with end stage renal disease (ESRD). The research has led to the development of a ground-breaking prototype device. In-house lab testing of the prototype have shown positive results and animal stu

NEW YORK, July 9, 2019 /PRNewswire/ -- 1Vision, a wholly owned subsidiary of HMS Technologies, Inc. (

MINNEAPOLIS, July 9, 2019 /PRNewswire/ -- Leslie Taha is a highly acclaimed African American cartoonist whose cartoon panel (and book) titled, "Off My Meds" has been lauded by many top celebrities in the comedy world (See the complete list at

COLUMBIA, S.C., July 9, 2019 /PRNewswire/ -- Columbia-area operator of mass transportation, The COMET, will help more residents get to the doctor and other medical appointments, thanks to a com

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., announced today the opening of its Eisai Center for Genetics Guided Dementia Discovery ("G2D2"), a new exploratory research facility located in Cambridge, Mass. Integrating cutting-edge strengths in human genetics, data sciences

ATLANTA, July 9, 2019 /PRNewswire/ -- In keeping with its promise to provide $100,000 in complimentary orthodontic care over three years to deserving children in Georgia, the

SAN RAFAEL, Calif., July 9, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of pharmaceutical veteran and former Johnson & Johnson executive, Liz McKee Anderson, to its Board of Directors effective J

NEW YORK, July 9, 2019 /PRNewswire/ -- The Mesothelioma Victims Center specializes in providing one of the nation's complete services for construction workers, elec